Depressive symptoms in urticaria patients treated with first- or second-generation histamine 1 receptor antagonists [8]

Journal of Clinical Psychopharmacology

Volumn 27, Issue 4, 2007, Pages 404-406

  Kalogeromitros, Dimitris ^a   Papageorgiou, Charalabos ^b,c   Gregoriou, Stamatis ^c   Chatziantonakis, Nikolaos ^c   Makris, Michael ^a   Spanoudaki, Nectaria ^a   Rabavilas, Andreas ^c   Rigopoulos, Dimitris ^a   Theoharides, Theoharis C ^a,d  

^a UNIVERSITY OF ATHENS   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY MENTAL HEALTH RESEARCH INSTITUTE   (Greece)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CETIRIZINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HYDROXYZINE;

ADULT; AGE DISTRIBUTION; CHRONIC URTICARIA; CONFUSION; CONSTIPATION; CONTROLLED STUDY; DECREASED APPETITE; DEPRESSION; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE EXACERBATION; DRUG EFFICACY; FATIGUE; FEMALE; FISHER EXACT TEST; HOPELESSNESS; HUMAN; IRRITABILITY; LETTER; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MOOD DISORDER; PATHOLOGICAL CRYING; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; PSYCHOMOTOR RETARDATION; RATING SCALE; RESTLESSNESS; SEX RATIO; SIDE EFFECT; SLEEP DISORDER; STATISTICAL SIGNIFICANCE; SUICIDAL BEHAVIOR; TACHYCARDIA; TREATMENT DURATION; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; AGED; CETIRIZINE; DEPRESSIVE DISORDER; FEMALE; HISTAMINE H1 ANTAGONISTS; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; HYDROXYZINE; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; URTICARIA;

EID: 34447498646     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000264994.24148.d7     Document Type: Letter

References (19)

1. Weldon DR. Quality of life in patients with urticaria. Allergy Asthma Proc. 2006;27:96-99.
2. Grob JJ, Gaudy-Marqueste C. Urticaria and quality of life. Clin Rev Allergy Immunol. 2006;30:47-51.
3. Staubach P, Eckhardt-Henn A, Dechene M, et al. Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity. Br J Dermatol. 2006;154:294-298.
4. Hashiro M, Okumura M. Anxiety, depression, psychosomatic symptoms and autonomic nervous function in patients with chronic urticaria. J Dermatol Sci. 1994;8:129-135.
5. Gupta MA, Gupta AK, Schork NJ, et al. Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria. Psychosom Med. 1994;56:36-40.
6. Gupta MA, Gupta AK. Psychiatric and psychological co-morbidity in patients with dermatologic disorders: epidemiology and management. Am J Clin Dermatol. 2003;4:833-842.
7. Lee EE, Maibach HI. Treatment of urticaria. An evidence-based evaluation of antihistamines. Am J Clin Dermatol. 2001;2:27-32.
8. Greaves MW. Antihistamines in dermatology. Skin Pharmacol Physiol. 2005;18:220-229.
9. Golightly LK, Greos LS. Second-generation antihistamines: actions and efficacy in the management of allergic disorders. Drugs. 2005;65:341-384.
10. YosipovitchG,AnsariN,GoonA,et al. Clinical characteristics of pruritus in chronic idiopathic urticaria. Br J Dermatol. 2002;147:32-36.
11. Tilles SA. Approach to therapy in chronic urticaria: when benadryl is not enough. Allergy Asthma Proc. 2005;26:9-12.
12. Gupta MA, Guptat AK. The use of antidepressant drugs in dermatology. J Eur Acad Dermatol Venereol. 2001;15:512-518.
13. Zung WW. A self-rating depression scale. Arch Gen Psychiatry. 1965;12:63-70.
14. Bender BG, Berning S, Dudden R, et al. Sedation and performance impairment of diphenhydramine and second-generation antihistamines: a meta-analysis. J Allergy Clin Immunol. 2003;111:770-776.
15. Furey ML, Drevets WC. Antidepressant efficacy of the antimuscarinic drug scopolamine. A randomized, placebo controlled clinical trial. Arch Gen Psych. 2006;63:1121-1129.
16. Ferreri M, Hantouche EG. Recent clinical trials of hydroxyzine in generalized anxiety disorder. Acta Psychiatr Scand Suppl. 1998;393:102-108.
17. Goldsobel AB, Rohr AS, Siegel SC, et al. Efficacy of doxepin in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol. 1986;78:867-873.
18. Karlson B, Osterberg K, Orbaek P. Euroquest: the validity of a new symptom questionnaire. NeuroToxicol. 2000;21:783-789.
19. Chorpita BF. The tripartite model and dimensions of anxiety and depression: an examination of structure in a large school sample. J Abnorm Child Psychol. 2002;30:177-190.